Your session is about to expire
← Back to Search
Active Colonoscopy Choice for Colorectal Cancer (CRC45+ Trial)
N/A
Waitlist Available
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 4 weeks from receiving the initial mychart message
Awards & highlights
CRC45+ Trial Summary
This trial will test 3 different approaches to getting people to get screened for colon cancer.
Eligible Conditions
- Health Screening
- Colorectal Cancer
CRC45+ Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ within 4 weeks from receiving the initial mychart message
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 4 weeks from receiving the initial mychart message
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Overall completion of any Colorectal Cancer Screening test
Secondary outcome measures
CRC screening order placed by any modality
Colorectal cancer screening uptake by modality
Selection of modality in MyChart Survey
CRC45+ Trial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: FIT ChoiceExperimental Treatment1 Intervention
This group will receive a tailored message via MyChart with information about CRC screening and using the FIT kit for noninvasive screening. They will then have to actively choose if they want CRC screening with a FIT kit vs no screening. If they opt for screening, the investigators will mail them a FIT kit.
Group II: Dual ChoiceExperimental Treatment1 Intervention
This group will receive a tailored message via MyChart with information about CRC screening and using either the FIT kit or colonoscopy for CRC screening. They will then have to actively choose if they want CRC screening with a FIT kit, a colonoscopy, or no screening. If they opt for screening, the investigators will either mail them a FIT kit or direct them to our patient navigators to schedule a colonoscopy, depending on their choice.
Group III: Colonoscopy ChoiceExperimental Treatment1 Intervention
This group will receive a tailored message via MyChart with information about CRC screening and colonoscopy for CRC screening. They will then have to actively choose if they want CRC screening with a colonoscopy vs no screening. If they opt for screening, the investigators will direct them to our patient navigators to get scheduled for a colonoscopy.
Group IV: Standard of CareActive Control1 Intervention
No Intervention-"Standard Care"
UCLA Health has a mailed FIT outreach program. This group will receive standard FIT mailer protocol. They will receive a tailored MyChart message indicating the importance of CRC screening and not be presented with a choice for screening modalities.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Active Dual Choice
2022
N/A
~20510
Active FIT Choice
2022
N/A
~20510
Active Colonoscopy Choice
2022
N/A
~20510
Find a Location
Who is running the clinical trial?
UCLA Department of MedicineUNKNOWN
3 Previous Clinical Trials
48,389 Total Patients Enrolled
UCLA David Geffen School of MedicineUNKNOWN
4 Previous Clinical Trials
96,389 Total Patients Enrolled
University of California, Los AngelesLead Sponsor
1,530 Previous Clinical Trials
10,257,693 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger